**Core Concept**
Ethosuximide is a specialized antiepileptic drug that selectively targets absence seizures (petit mal seizures) by blocking T-type calcium channels in thalamocortical neurons, thereby stabilizing hyperexcitable thalamic circuits.

**Why the Correct Answer is Right**
Ethosuximide specifically acts on T-type calcium channels in the thalamus, reducing abnormal thalamocortical oscillations that underlie petit mal seizures. It has a narrow spectrum of activity, effective only for absence seizures and not for other seizure types. This makes it the drug of choice in pediatric absence epilepsy with minimal off-target effects.

**Why Each Wrong Option is Incorrect**
Option A: Lamotrigine has broad-spectrum activity and is used in generalized and focal seizures, not limited to absence seizures.
Option C: Phenytoin is a broad-spectrum anticonvulsant effective in tonic-clonic, partial, and generalized seizures, not specifically for petit mal.
Option D: Primidone is a broad-spectrum agent used in various seizure types, including generalized tonic-clonic and absence, but lacks specificity and is not first-line for absence seizures.

**Clinical Pearl / High-Yield Fact**
Ethosuximide is the only antiepileptic drug with proven, specific efficacy in absence seizures and is preferred in children with petit mal seizures—its narrow spectrum makes it ideal for targeted therapy without broad neurotoxicity.

✓ Correct Answer: B. Ethosuximide